次要终点为日间和夜间症状评分。
Secondary endpoints included daytime and nighttime symptom scores.
次要终点是死于心血管疾病和心肌梗死。
The secondary end point was the composite of death from cardiovascular causes and myocardial infarction.
心绞痛复发率及再入院率（次要终点）。
Recurrence angina and readmission were the secondary endpoint.
其他非磁共振成像次要终点包括复发和残疾。
Other non-MRI secondary end points included relapses and disability.
次要终点为心血管事件、肾功能和微血管病变。
Secondary end points were cardiovascular events, renal function, and microvascular morbidity.
次要终点是蛋白尿水平的改变和肾脏疾病的进展程度。
Secondary end points included changes in the level of proteinuria and the rate of progression of renal disease.
总生存率及安全性被包括在研究的次要终点中进行评估。
Overall survival and safety are among the secondary endpoints that will be assessed in the trial.
次要终点为尿蛋白水平的改变或肾脏疾病进展的发生率。
Secondary end points included changes in the level of proteinuria and the rate of progression of renal disease.
次要终点包括氧合、呼吸困难程度、以及生活质量的改变。
Key secondary outcomes included changes in oxygenation, degree of dyspnea, and quality of life.
一些阳性的次要终点的结果产生了对进一步研究的临床均势。
The presence of some positive secondary outcomes creates clinical equipoise for further research.
然而，在很多次要终点方面的研究结果有很强的趋势和统计学意义。
However, there were strong trends and a number of statistically significant findings from a number of secondary endpoints.
次要终点包括IRC评估的总生存期(OS)和总缓解率(ORR)。
Secondary end points included overall survival (OS) and overall response rate (ORR) per IRC.
主要终点是持续性哮鸣或哮喘，次要终点包括下呼吸道感染、哮喘加重、湿疹和变应性致敏。
The primary end point was persistent wheeze or asthma, and the secondary end points included lower respiratory tract infections, asthma exacerbations, eczema, and allergic sensitization.
次要终点包括其他各种磁共振成像(MRI)的措施、钆病变的体积、T2和T1黑洞的体积。
Secondary end points included various other magnetic resonance imaging (MRI) measures, including gadolinium lesion volume and T2 and T1 black hole volume.
次要终点指标包括1秒呼出气量，峰流速，急救用药次数，夜间觉醒次数各基因型组之间均无显著差异。
Secondary endpoints, including forced expiratory volume in 1 s, peak expiratory flow, use of as-needed medication, and number of nights with awakenings were similar between genotype groups.
次要终点包括应答率，应答时间和安全性。196例病人死亡后进行最终的分析，98例病人死亡后进行间断分析。
Secondary end points included the response rate, response duration, and safety. A final analysis was planned after 196 deaths and an interim analysis after 98 deaths.
次要观察终点包括总生存期，安全性，患者对治疗设施的满意度和理解以及医疗资源的利用。
Secondary endpoints included overall survival, safety, patients' satisfaction with and perception of treatment convenience, and medical resource utilization.
但中位总生存期，次要观察终点，联合组为20.5个月，而单药治疗组为20.6个月。
But median overall survival, a secondary end point, was 20.5 months in the combination group and 20.6 months in the monotherapy group.
首要终点指标是生存期，次要指标包括肿瘤缓解、症状改善、体重变化、肝功能改善等。
Primary destination indicator is survival, secondary indicators include tumor response rate, symptoms improvement, weight change and liver function improvement.
主要观察终点是2 4小时复律成功率，次要观察终点是8小时复律成功率。
The primary end point was rate of cardioversion within 24 hours, the secondary end point was rate of cardioversion at 8 hours.
次要复合终点为不稳定性心绞痛附加住院的主要转归。
The key secondary composite outcome was the primary outcome plus hospitalization for unstable angina.
次要复合终点为不稳定性心绞痛附加住院的主要转归。
The key secondary composite outcome was the primary outcome plus hospitalization for unstable angina.
应用推荐